Rapid Dose Therapeutics Corp. Stock
Equities
DOSE
CA75339A1012
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.22 CAD | -.--% | -8.33% | +33.33% |
Sales 2022 | 1.75 2.39 | Sales 2023 | 0.72 0.98 | Capitalization | 9.32M 12.7M |
---|---|---|---|---|---|
Net income 2022 | -8M -10.9M | Net income 2023 | -3M -4.09M | EV / Sales 2022 | 15,898,275 x |
Net Debt 2022 | 1.4M 1.9M | Net Debt 2023 | 2.1M 2.86M | EV / Sales 2023 | 15,894,851 x |
P/E ratio 2022 |
-3.01
x | P/E ratio 2023 |
-2.44
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 90.24% |
1 week | -8.33% | ||
1 month | -6.38% | ||
3 months | +25.71% | ||
6 months | +37.50% | ||
Current year | +33.33% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Upsdell
CEO | Chief Executive Officer | - | 17-05-02 |
Doug Hyland
DFI | Director of Finance/CFO | - | 20-02-27 |
Corporate Officer/Principal | - | 19-01-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Donald Sheldon
LAW | General Counsel | 77 | 19-12-05 |
John McKimm
BRD | Director/Board Member | - | 23-04-13 |
Director/Board Member | - | 20-08-12 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-30 | 0.22 | -4.35% | 22,330 |
24-05-29 | 0.23 | +4.55% | 164,318 |
24-05-28 | 0.22 | -8.33% | 33,000 |
24-05-24 | 0.24 | +9.09% | 76,500 |
Delayed Quote Canadian Securities Exchange, May 30, 2024 at 03:36 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+33.33% | 19.69M | |
-53.52% | 98.62M |
- Stock Market
- Equities
- DOSE Stock